Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
INSULET CORP | Director | Common Stock | 14.5K | $2.97M | $205.07 | May 21, 2021 | Direct |
COLLEGIUM PHARMACEUTICAL, INC | Director | Common Stock | 54.8K | $1.77M | $32.30 | May 16, 2024 | Direct |
INSULET CORP | Director | Stock Option (Right to Buy) | 0 | May 21, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
COLL | COLLEGIUM PHARMACEUTICAL, INC | May 16, 2024 | 1 | $0 | 4 | May 16, 2024 | Director |
COLL | COLLEGIUM PHARMACEUTICAL, INC | May 18, 2023 | 1 | $0 | 4 | May 19, 2023 | Director |
COLL | COLLEGIUM PHARMACEUTICAL, INC | May 19, 2022 | 1 | $0 | 4 | May 23, 2022 | Director |
PODD | INSULET CORP | May 21, 2021 | 6 | -$1.26M | 4 | May 25, 2021 | Director |
COLL | COLLEGIUM PHARMACEUTICAL, INC | May 20, 2021 | 1 | $0 | 4 | May 24, 2021 | Director |